好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Neuro-Oncology

Tuesday 05/01/07
02:00 PM - 03:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Neuro-oncology
No CME available
Event Timeline
02:00 PM - 03:30 PM Abstract 001 - Salvage Chemotherapy with CPT-11 for Recurrent Temozolomide-Refractory Anaplastic Oligodendroglioma
02:00 PM - 03:30 PM Abstract 002 - Temozolomide in Gliomatosis Cerebri: A Multi-Center Retrospective Study of the AINO (Italian Association for Neuro-Oncology)
02:00 PM - 03:30 PM Abstract 003 - Age at Diagnosis, Treatment Combination and Survival among Elderly Patients with Anaplastic Astrocytoma (AA) and Glioblastoma Multiforme (GBM)
02:00 PM - 03:30 PM Abstract 004 - Experience with Hyperbaric Oxygen Therapy for Radiation Induced Nervous System Injury
02:00 PM - 03:30 PM Abstract 005 - Ocular Presentation of Primary Central Nervous System Lymphoma: An International PCNSL Collaborative Group Report
02:00 PM - 03:30 PM Abstract 006 - Clinical and Pathological Analysis of Paraneoplastic Anti-NMDA Receptor Encephalitis in 16 Patients
Faculty Disclosures
Herbert B. Newton, MD No disclosure on file
Nina Paleologos, MD No disclosure on file
Michael Glantz, MD, FAAN No disclosure on file
Josep O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Myrna R. Rosenfeld, MD, PhD, FAAN Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. An immediate family member of Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Lamson Dugan & Murray LLP. The institution of an immediate family member of Dr. Rosenfeld has received research support from Sage Therapeutics. The institution of an immediate family member of Dr. Rosenfeld has received research support from Edmond J. Safra Foundation. The institution of an immediate family member of Dr. Rosenfeld has received research support from La Caixa Foundation. The institution of an immediate family member of Dr. Rosenfeld has received research support from Spanish Ministry of Health. The institution of an immediate family member of Dr. Rosenfeld has received research support from Department of Health, Government of Catalunya. Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Rosenfeld has received intellectual property interests from a discovery or technology relating to health care. Dr. Rosenfeld has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Rosenfeld has received publishing royalties from a publication relating to health care. Dr. Rosenfeld has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Rosenfeld has received publishing royalties from a publication relating to health care.
Marc Chamberlain, MD No disclosure on file
David Schiff, MD, FAAN Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care.
No disclosure on file
Arthur D. Forman, MD No disclosure on file
Ulrich J. Herrlinger No disclosure on file
Edward A. Neuwelt, MD No disclosure on file
Francesc R. Graus, MD Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
Deborah T. Blumenthal, MD Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Affaires Medicales. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure Israel Ltd. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Oncology. The institution of Dr. Blumenthal has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Merck Sharp and Dohme.
David R. Lynch, MD, PhD The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Riccardo Soffietti, MD Dr. Soffietti has nothing to disclose.
Jeffrey J. Raizer, MD No disclosure on file
Erdem Tuzun Erdem Tuzun has nothing to disclose.
Sean Grimm, MD Dr. Grimm has nothing to disclose.
Lauren E. Abrey, MD No disclosure on file
Tracy T. Batchelor, MD, MPH Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Brian P. O'Neill, MD, FAAN No disclosure on file
Antonio M. Omuro, MD, FAAN Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo.
James Rubenstein No disclosure on file
Roberto Ruda, MD Dr. Ruda has nothing to disclose.
Sajeel Chowdhary, MD Dr. Chowdhary has received personal compensation for serving as an employee of Merck. Dr. Chowdhary has received personal compensation for serving as an employee of Servier. Dr. Chowdhary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Chowdhary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier.
John Maldonado No disclosure on file
Nazely Ashikian, MD Dr. Ashikian has nothing to disclose.
Robert Arbuckle, MD No disclosure on file
Marko Petrovic, MD Dr. Petrovic has nothing to disclose.
Imane S. Chibane, MD No disclosure on file
Michael Shaw No disclosure on file
Ariana M. Frontario, DO Dr. Frontario has nothing to disclose.